KINIKSA PHARMACEUTICALS LTD
COM CL A · CUSIP G5269C101
2
institutional holders
+0 vs Q1 2025
100.9k
shares reported held*
$2.8mreported value*
0 new
0 added
2 reduced
0 sold out
net sold ≈ $188.2k (-6.8k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $27.67.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 105 |
| Q4 2022 | 126 |
| Q1 2023 | 134 |
| Q2 2023 | 129 |
| Q3 2023 | 136 |
| Q4 2023 | 144 |
| Q1 2024 | 156 |
| Q2 2024 | 5 |
| Q3 2024 | 2 |
| Q4 2024 | 2 |
| Q1 2025 | 2 |
| Q2 2025 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2023 | 66 | 54 |
| Q4 2023 | 62 | 76 |
| Q1 2024 | 84 | 68 |
| Q2 2024 | 2 | 149 |
| Q3 2024 | 1 | 4 |
| Q4 2024 | 1 | 0 |
| Q1 2025 | 0 | 2 |
| Q2 2025 | 0 | 2 |
Biggest buyers
| None |
Biggest sellers
| HARBOR CAPITAL ADVISORS, INC. | Reduced | -6.8k |
| Birchview Capital, LP | Reduced | -6 |
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| HARBOR CAPITAL ADVISORS, INC. 0.08% of their portfolio | 70.9k $2.0m | Reduced -6.8k |
| Birchview Capital, LP 0.82% of their portfolio | 30.0k $830.1k | Reduced -6 |